Barranco CRS
Lima 18
1 studies enrolling now · 14 studies all time
What they study most
COVID-19, Cardiovascular Diseases, HIV, HIV Infections, HIV-1 Infection, HIV-1-infection, MPOX, Major Depressive Disorder, Mild Neurocognitive Disorder, SARS-CoV-2, Tuberculosis
Studies at this site
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV — Paused
- Study of Tecovirimat for Human Mpox Virus — Stopped early
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection — Starting soon
- Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men — Completed
- Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 — Completed
- Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults — Completed
- Early ART to Limit Infection and Establishment of Reservoir — Completed
- Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults — Completed
- Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 — Completed
- A Study of Immune Responses to the Virus That Causes COVID-19 — Completed
- Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men — Completed
- Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) — Completed
- Antigenic Competition in HIV Preventive Vaccines — Completed
- HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV — Completed